{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T04:54:49Z","timestamp":1767588889286,"version":"3.48.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-025-01780-4","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T12:07:07Z","timestamp":1747310827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transdifferentiation of Hairy Cell Leukemia to Lytic and Mass-Producing Histiocytic Sarcoma: A Novel Head and Neck Example and Review of the Literature"],"prefix":"10.1007","volume":"19","author":[{"given":"Austin J.","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parnaz","family":"Daneshpajouhnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mugdha","family":"Patwardhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaizhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren P.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"1780_CR1","doi-asserted-by":"crossref","unstructured":"Miranda RN, Briggs RC, Kinney MC et al (2000) Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Mod Pathol Off J U S Can Acad Pathol Inc. 2000;13(12):1308\u201314","DOI":"10.1038\/modpathol.3880239"},{"key":"1780_CR2","doi-asserted-by":"crossref","unstructured":"Kommalapati A, Tella SH, Go RS et al (2019) Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma. Leuk Lymphoma. 2019;60(2):553\u20135","DOI":"10.1080\/10428194.2018.1492128"},{"key":"1780_CR3","doi-asserted-by":"crossref","unstructured":"Campo E, Swerdlow SH, Harris NL et al (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019","DOI":"10.1182\/blood-2011-01-293050"},{"key":"1780_CR4","doi-asserted-by":"crossref","unstructured":"Facchetti F, Pileri SA, Lorenzi L et al (2017) Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases. Virchows Arch Int J Pathol. 2017;471(4):467\u201389","DOI":"10.1007\/s00428-017-2176-1"},{"key":"1780_CR5","doi-asserted-by":"crossref","unstructured":"Xiao W, Amador C, Cook JR et al (2023) B-cell lineage neoplasms transdifferentiating into histiocytic\/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH\/EAHP Workshop. Am J Clin Pathol. 2023;159(6):522\u201337","DOI":"10.1093\/ajcp\/aqad022"},{"key":"1780_CR6","doi-asserted-by":"crossref","unstructured":"Feldman AL, Arber DA, Pittaluga S et al (2008) Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111(12):5433","DOI":"10.1182\/blood-2007-11-124792"},{"key":"1780_CR7","doi-asserted-by":"crossref","unstructured":"Shen CN, Burke ZD, Tosh D (2004) Transdifferentiation, Metaplasia and Tissue Regeneration. Organogenesis. 2004;1(2):36","DOI":"10.4161\/org.1.2.1409"},{"key":"1780_CR8","doi-asserted-by":"crossref","unstructured":"Bueno-Costa A, Pi\u00f1eyro D, Soler M et al (2019) B-cell leukemia transdifferentiation to macrophage involves reconfiguration of DNA methylation for long-range regulation. Leukemia. 2019;34(4):1158","DOI":"10.1038\/s41375-019-0643-1"},{"key":"1780_CR9","doi-asserted-by":"crossref","unstructured":"Egan C, Nicolae A, Lack J et al (2020) Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. Haematologica. 2020;105(4):951\u201360","DOI":"10.3324\/haematol.2019.230375"},{"key":"1780_CR10","doi-asserted-by":"crossref","unstructured":"Takahashi E, Nakamura S (2013) Histiocytic Sarcoma: An Updated Literature Review Based on the 2008 WHO Classification. J Clin Exp Hematop. 2013;53(1):1\u20138","DOI":"10.3960\/jslrt.53.1"},{"key":"1780_CR11","doi-asserted-by":"crossref","unstructured":"So H, Kim SA, Yoon DH et al (2014) Primary Histiocytic Sarcoma of the Central Nervous System. Cancer Res Treat Off J Korean Cancer Assoc. 2014;47(2):322","DOI":"10.4143\/crt.2013.163"},{"key":"1780_CR12","unstructured":"Legarrea JMA, Alves HS, Chaves RRM et al (2024) Histiocytic sarcoma affecting the oral cavity: a clinical, pathologic and molecular study - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology [Internet]. 2024 [cited 2024 Nov 17]. Available from: https:\/\/www.oooojournal.net\/article\/S2212-4403(24)00368-7\/abstract"},{"key":"1780_CR13","doi-asserted-by":"crossref","unstructured":"Andersen KF, Sj\u00f6 LD, Kampmann P et al (2021) Histiocytic Sarcoma: Challenging Course, Dismal Outcome. Diagnostics. 2021;11(2):310","DOI":"10.3390\/diagnostics11020310"},{"key":"1780_CR14","doi-asserted-by":"crossref","unstructured":"Vos JA, Abbondanzo SL, Barekman CL et al (2005) Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol. 2005;18(5):693\u2013704","DOI":"10.1038\/modpathol.3800346"},{"key":"1780_CR15","doi-asserted-by":"crossref","unstructured":"Go H, Jeon YK, Huh J et al (2014) Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology. 2014;65(2):261\u201372","DOI":"10.1111\/his.12416"},{"key":"1780_CR16","doi-asserted-by":"crossref","unstructured":"Kemps PG, Hebeda KM, Pals ST et al (2020) Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation. J Pathol Clin Res. 2020;7(1):10","DOI":"10.1002\/cjp2.177"},{"key":"1780_CR17","doi-asserted-by":"crossref","unstructured":"Shimono J, Miyoshi H, Arakawa F et al (2017) Prognostic factors for histiocytic and dendritic cell neoplasms. Oncotarget. 2017;8(58):98723","DOI":"10.18632\/oncotarget.21920"},{"key":"1780_CR18","unstructured":"Philip DSJ, Sherief A, Narayanan G et al (2022) Histiocytic Sarcoma: Clinical Features and Outcomes of Patients Treated at a Tertiary Cancer Care Center. Cureus. 2022;14(6):e25814"},{"key":"1780_CR19","doi-asserted-by":"crossref","unstructured":"Oka S, Ono K, Nohgawa M (2021) Successful Treatment of Incidental Histiocytic Sarcoma Concomitant with Laryngeal Carcinoma. Intern Med. 2021;60(16):2659","DOI":"10.2169\/internalmedicine.6948-20"},{"key":"1780_CR20","doi-asserted-by":"crossref","unstructured":"Sharma S, Das P, Dinda AK et al (2016) Disseminated histiocytic sarcoma in a child: a clinicopathological dichotomy with 8 years survival. BMJ Case Rep. 2016;2016:bcr2015213871","DOI":"10.1136\/bcr-2015-213871"},{"key":"1780_CR21","doi-asserted-by":"crossref","unstructured":"Idbaih A, Mokhtari K, Emile JF et al (2014) Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib. Neurology. 2014;83(16):1478\u201380","DOI":"10.1212\/WNL.0000000000000880"},{"key":"1780_CR22","unstructured":"Clinical Trials Search - My Cancer Genome [Internet]. [cited 2024 Oct 29]. Available from: https:\/\/www.mycancergenome.org\/content\/clinical_trials\/#diseases=Histiocytic%20Sarcoma"},{"key":"1780_CR23","doi-asserted-by":"crossref","unstructured":"Schlick K, Aigelsreiter A, Pichler M et al (2012) Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases. Onkologie. 2012;35(7\u20138):447\u201350","DOI":"10.1159\/000340066"},{"key":"1780_CR24","doi-asserted-by":"crossref","unstructured":"Chai KL, McKelvie P, Bazargan A (2018) BRAF-mutated hairy cell leukaemia with transdifferentiation to histiocytic sarcoma\u2013 A case report. Pathology (Phila). 2018;50:S102","DOI":"10.1016\/j.pathol.2017.12.286"},{"key":"1780_CR25","doi-asserted-by":"crossref","unstructured":"Michonneau D, Kaltenbach S, Derrieux C et al (2014) BRAFV600E Mutation in a Histiocytic Sarcoma Arising From Hairy Cell Leukemia. J Clin Oncol. 2014;32(35):e117\u201321","DOI":"10.1200\/JCO.2013.49.0078"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-025-01780-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-025-01780-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-025-01780-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T04:52:59Z","timestamp":1767588779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-025-01780-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1780"],"URL":"https:\/\/doi.org\/10.1007\/s12105-025-01780-4","relation":{},"ISSN":["1936-0568"],"issn-type":[{"type":"electronic","value":"1936-0568"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent To Participate"}},{"value":"For this type of study consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Reprints are not available from the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Media"}},{"value":"Statement of use of AI technology.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimers"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"62"}}